Clinical trials

  • RO7121932 for Multiple sclerosis
  • Bevacizumab for Colorectal peritoneal metastases
  • Rosuvastatin for Healthy volunteers
  • Adipose tissue-derived mesenchymal stromal cells for Primary progressive multiple sclerosis
  • IPTACOPAN for C3 glomerulopathy|Idiopathic immune-complex membranoproliferative glomerulonephritis
  • ZIRCONIUM (89ZR) CREFMIRLIMAB BERDOXAM for Breast cancer|Esophageal cancer|Melanoma|Non-small cell lung cancer
  • MPS-112, MPS-106, MPS-213, MPS-102, MPS-216, MPS-103, MPS-215, MPS-214, D-ALA-LYS-CHA-VAL-ALA-ALA-TRP-THR-LEU-LYS-ALA-ALA-D-ALA, MPS-200 for Non-small cell lung cancer
  • VOLRUSTOMIG for Non-small cell lung cancer | Solid tumours
  • PF-06835375 for Primary immune thrombocytopenia
  • MAGNESIUM HYDROXIDE for Advanced cancer
  • iptacopan hydrochloride for Lupus nephritis | Lupus Nephritis Class III-IV, +/- V
  • TILSOTOLIMOD SODIUM for Cutaneous melanoma (pT3-4, clinically node-negative, M0)